Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
GPR75 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 75 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR75 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR68 Biologics Sequence Review Report 2026: G protein-coupled receptor 68 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR68 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
ADAMTS4 Biologics Sequence Review Report 2026: A disintegrin and metalloproteinase with thrombospondin motifs 4 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of ADAMTS4 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR45 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 45 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR45 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR61 Biologics Sequence Review Report 2026: G protein-coupled receptor 61 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR61 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
LILRB3 Biologics Sequence Review Report 2026: Leukocyte immunoglobulin-like receptor subfamily B member 3 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of LILRB3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR62 Biologics Sequence Review Report 2026: G protein-coupled receptor 62 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR62 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR63 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 63 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR63 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR34 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 34 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR34 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR27 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 27 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR27 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR32 Biologics Sequence Review Report 2026: Probable G protein-coupled receptor 32 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR32 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
8 min read
GPR32P1 Biologics Sequence Review Report 2026: Putative G protein-coupled receptor GPR32P1 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of GPR32P1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.